Breaking News, Collaborations & Alliances

Cytovance, Horizon Sign License Agreement

For the use of their HD-BIOP3 Suspension adapted GS null CHO K1 cells

Cytovance Biologics signed a non-exclusive license with Horizon Discovery for the use of their HD-BIOP3 Suspension adapted GS null CHO K1 cells.    The Horizon CHO GS -/-  cell line is available immediately for cell line development services performed out of their Oklahoma City based facilities. The new cell line is part of a toolbox approach to CHO Cell Line Development, making the Cytovance offering of multiple cell lines for each molecule unique in the CDMO industry.   “We’re ex...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters